NVCT icon

Nuvectis Pharma

12 hedge funds and large institutions have $6.34M invested in Nuvectis Pharma in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
+1
Holders Change %
+9.09%
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
3
Increased
7
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.64M +$73.5K +5,604 +3%
BWP
2
Baldwin Wealth Partners
Massachusetts
$1.89M +$138K +10,500 +8%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$459K +$47.9K +3,654 +12%
Millennium Management
4
Millennium Management
New York
$323K +$323K +24,667 New
EDRH
5
Edmond de Rothschild Holding
Switzerland
$322K +$322K +24,570 New
BlackRock
6
BlackRock
New York
$178K +$44.5K +3,395 +33%
State Street
7
State Street
Massachusetts
$176K +$22.3K +1,700 +15%
Man Group
8
Man Group
United Kingdom
$168K
Jane Street
9
Jane Street
New York
$145K +$145K +11,086 New
Morgan Stanley
10
Morgan Stanley
New York
$40.8K +$36.9K +2,814 +935%
TRCT
11
Tower Research Capital (TRC)
New York
$3K -$13.3K -1,109 -82%
Bank of America
12
Bank of America
North Carolina
$2.15K +$1.99K +152 +1,267%
Wells Fargo
13
Wells Fargo
California
$328
SM
14
Sabby Management
Florida
-$4.41M -587,452 Closed
VF
15
Virtu Financial
New York
-$93K -12,418 Closed